Federal contract award
75A50119F33003
RANDOMIZED, THREE-WAY CROSSOVER STUDY TO ASSESS THE BIOAVAILABILITY AND PHARMACOKINETICS OF A SINGLE DOSE OF ATROPINE ADMINISTERED SUBLINGUALLY IN HEALTHY ADULT VOLUNTEERS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | HHSO100201400004I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $1.2M |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $1.2M |
| Start date | Jul 18, 2019 |
| Current end date | Jul 17, 2020 |
| Potential end date | Jul 17, 2020 |
| Latest award activity | Sep 22, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 22, 2025 | P00004 | $-342.9K | ATROPINE CLINICAL SERVICES FOR A BIOAVAILABILITY CLINICAL STUDY. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.